These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 36036290)
1. Identification of the molecular subtype and prognostic characteristics of pancreatic cancer based on CD8 + T cell-related genes. Xu D; Wang Y; Chen Y; Zheng J Cancer Immunol Immunother; 2023 Mar; 72(3):647-664. PubMed ID: 36036290 [TBL] [Abstract][Full Text] [Related]
2. CD8 Zhang M; Ma J; Guo Q; Ding S; Wang Y; Pu H Front Immunol; 2022; 13():806877. PubMed ID: 35273597 [TBL] [Abstract][Full Text] [Related]
3. Systematic Analysis of Molecular Subtypes and Immune Prediction Based on CD8 T Cell Pattern Genes Based on Head and Neck Cancer. Yanwei L; He F; Liu S; Pan Z J Oncol; 2022; 2022():1500493. PubMed ID: 36059811 [TBL] [Abstract][Full Text] [Related]
4. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma. Li J; Yin J; Li W; Wang H; Ni B Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100 [TBL] [Abstract][Full Text] [Related]
5. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma. Huang Y; Gong P; Su L; Zhang M Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210 [TBL] [Abstract][Full Text] [Related]
6. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma. Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802 [TBL] [Abstract][Full Text] [Related]
7. Systematic Analysis of Molecular Subtypes Based on the Expression Profile of Immune-Related Genes in Pancreatic Cancer. Ke M Oxid Med Cell Longev; 2022; 2022():3124122. PubMed ID: 36567857 [TBL] [Abstract][Full Text] [Related]
8. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324 [TBL] [Abstract][Full Text] [Related]
9. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma. Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987 [TBL] [Abstract][Full Text] [Related]
10. Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma. Chen B; Deng T; Deng L; Yu H; He B; Chen K; Zheng C; Wang D; Wang Y; Chen G BMC Cancer; 2021 Nov; 21(1):1211. PubMed ID: 34772375 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H Front Immunol; 2021; 12():769425. PubMed ID: 34804059 [TBL] [Abstract][Full Text] [Related]
12. A novel CD8 Lin F; Ke ZB; Xue YT; Chen JY; Cai H; Lin YZ; Li XD; Wei Y; Xue XY; Xu N Inflamm Res; 2023 Aug; 72(8):1665-1687. PubMed ID: 37578544 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
14. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma. Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178 [TBL] [Abstract][Full Text] [Related]
15. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253 [TBL] [Abstract][Full Text] [Related]
16. Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study. Wu G; Deng Z; Jin Z; Wang J; Xu B; Zeng J; Peng M; Wen Z; Guo Y Biomed Res Int; 2020; 2020():1346045. PubMed ID: 32596278 [TBL] [Abstract][Full Text] [Related]
17. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing. Li J; Han T; Wang X; Wang Y; Yang R; Yang Q Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299 [TBL] [Abstract][Full Text] [Related]
18. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Yan C; Niu Y; Li F; Zhao W; Ma L J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146 [TBL] [Abstract][Full Text] [Related]
19. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma. Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B Front Oncol; 2022; 12():915662. PubMed ID: 36033441 [TBL] [Abstract][Full Text] [Related]
20. Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development. Huang X; Zhang G; Tang T; Liang T Mol Cancer; 2021 Mar; 20(1):44. PubMed ID: 33648511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]